Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-40.35%
↓ 99% vs avg
Percentile
P18
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-20.23%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -40.35% |
| Q3 2025 | 29.86% |
| Q2 2025 | -22.23% |
| Q1 2025 | -39.91% |
| Q4 2024 | 11.37% |
| Q3 2024 | 4.41% |
| Q2 2024 | 7.32% |
| Q1 2024 | -58.44% |
| Q4 2023 | -115.38% |
| Q3 2023 | 18.09% |
| Q2 2023 | -37.49% |
| Q1 2023 | 0.00% |